Annapolis, Md.-based Luminis Health recorded an operating income of $4 million (0.6% operating margin) in the first half of fiscal 2026, up from an operating loss of $8.8 million (-1.4% margin) during the same period last year, according to its Feb. 9 financial report.
Luminis reported total operating revenue of $666.7 million during the six months ended Dec. 31, up from $627.8 million during the same period last year. The health system attributed the growth to a 5.3% increase in net patient revenue primarily due to annual rate increases from the Maryland Global Budget Revenue Model. Net patient service revenue was $646.2 million, up from $613.8 million.
The system said it continues to focus on collection improvement, denial management, quality incentive metrics and utilization review processes.
Total operating expenses were $662.7 million through the second quarter, up from $636.6 million during the same period last year. Salaries, wages and benefits totaled $354.4 million, up from $349.6 million. Supply costs were $118.9 million, up from $109.3 million. Purchased services totaled $163.1 million, up from $150.9 million.
“As with other healthcare organizations, the system continues to experience high medical and professional fees and labor costs, however, implemented cost-saving measures have contributed toward operating revenue growth outpacing operating expenses by 2.1% year over year,” Luminis said in the report.
The system reported a net income of $44.2 million through the second quarter of 2026, up from $16.3 million last year.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
